Nintedanib esylate
Nintedanib esylate (BIBF 1120 esylate) is a small molecule triple kinase inhibitor targeting VEGFR, FGFR, and PDGFR receptors. It is widely used in preclinical research to study angiogenesis, fibrosis, and oncology in both cellular assays and animal models.
Product Specifications
CAS Number
656247-18-6
Product Name Alternative
Nintedanib, Nintedanib esylate, Nintedanib Ethanesulfonate Salt, PDGFRβ, PDGFRα, PDGFR, FGFR, FGFR1, FGFR2, FGFR3, esylate, BIBF 1120 (esylate), BIBF1120, BIBF-1120, VEGFR3, VEGFR2, VEGFR1, VEGFR
Field of Research
Cardiovascular Research, Pharmacology & Drug Discovery, Signal Transduction
Purity
99.43% (May vary between batches)
Solubility
DMSO:101 mg/mL (155.44 mM)
Smiles
CCS (O) (=O) =O.COC (=O) c1ccc2c (NC (=O) \C2=C (/Nc2ccc (cc2) N (C) C (=O) CN2CCN (C) CC2) c2ccccc2) c1
Molecular Formula
C31H33N5O4.C2H6O3S
Molecular Weight
649.76
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog